The Distribution of Serum Prostate-Specific Antigen Levels Among American Men: Implications for Prostate Cancer Prevalence and Screening
- 5 April 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (10) , 1044-1051
Abstract
BACKGROUND The purpose of this study was to describe the distribution of serum prostate-specific antigen (PSA) among American men and to estimate the number of prevalent cases of biopsy detectable prostate cancer among men with normal serum PSA. METHODS We analyzed data of the National Health and Nutrition Examination Survey 2001–2002 (NHANES 2001–2002) data and combined these results with published data from the Prostate Cancer Prevention Trial (PCPT). RESULTS Most men in the US have a serum PSA ≤4.0 ng/ml, and mean and median serum PSA values rise steadily with age. There are an estimated 1,607,585 (95% CI 1,370,848–1,844,322) prevalent cases of biopsy detectable prostate cancer in men aged 62–85 years with a serum PSA ≤4 ng/ml. Among men aged 62–75 years, there are an estimated 1,252,143 (95% CI 1,054,677–1,449,609) prevalent cases, including an estimated 195,499 (95% CI 140,234–250,764) high-grade tumors. CONCLUSION A large number of prevalent cases of biopsy detectable prostate cancer exist in American men with a normal PSA. Prostate 66: 1044–1051, 2006.Keywords
This publication has 27 references indexed in Scilit:
- Prostate-Specific Antigen Levels in the United States: Implications of Various Definitions for AbnormalJNCI: Journal of the National Cancer Institute, 2005
- American Cancer Society Guidelines for the Early Detection of Cancer, 2005CA: A Cancer Journal for Clinicians, 2005
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- Effect of Verification Bias on Screening for Prostate Cancer by Measurement of Prostate-Specific AntigenNew England Journal of Medicine, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Screening Men for Prostate and Colorectal Cancer in the United StatesJAMA, 2003
- Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaignUrology, 2002
- Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSAUrology, 1999
- Reference ranges for serum prostate-specific antigen in black and white men without cancerUrology, 1998
- Serum Prostate-Specific Antigen in a Community-Based Population of Healthy MenJAMA, 1993